Product Images Cefpodoxime Proxetil

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Cefpodoxime Proxetil NDC 64980-402 by Rising Pharma Holdings, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 50 mg/5 mL (50 mL Bottle) - cefpodoxime fig1

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 50 mg/5 mL (50 mL Bottle) - cefpodoxime fig1

This is a product information sheet for Cefpodoxime Proxetil, an oral suspension medication used for bacterial infections. Each 5 mL of suspension contains Cejoxime Proxetil USP. The usual dosage of the medication can be found on the package insert. The medication must be stored in a cool place before and after constitution. Directions for use before and after constitution are provided, and the mixture can be used for up to 14 days. The product is distributed by Rising Pharmaceuticals, Inc. However, the batch and expiry dates are not specified.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 50 mg/5 mL Carton Label - cefpodoxime fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 50 mg/5 mL Carton Label - cefpodoxime fig2

Rising® tces-40250 Cefpodoxime Proxetil for Oral Suspension, USP is intended for treating bacterial infections. The package should be stored at a controlled room temperature of 20 to 25°C with exceptions at 15° to 30°C. If needed, store the constituted suspension in a refrigerator 2'to 8°C. (36" to 46°F). Before reconstitution, remove the desiccant capsule by pulling out two small rings, then discard. Follow the instructions for mixing, shake well before using, and keep the container tightly closed. The mixture may be used for 14 days, and the unused portion should be discarded after that. The package insert contains instructions on the dosage and administration.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 100 mg/5 mL (50 mL Bottle) - cefpodoxime fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 100 mg/5 mL (50 mL Bottle) - cefpodoxime fig3

This is a medication called Cefpodoxime Proxetil for Oral Suspension, USP that comes in a 50 mL bottle. Each 5 mL of suspension contains cefpodoxime proxetil USP equivalent to 100 mg cefpodoxime. It is important to consult the package insert for Dosage and Administration. This medication should not be used for injection. Unconstituted granules should be stored at 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F), and the constituted suspension should be stored in the refrigerator between 2° to 8°C (36" to 46°F). The desiccant capsule should be removed before reconstitution, and the bottle should be shaken before use. Once the mixture is constituted, it should be kept in a tightly closed container, and only used for 14 days. This medication should be kept out of the reach of children. It is distributed by Rising Pharmaceuticals, Inc. in Brook, NJ and made in India.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 100 mg/5 mL Carton Label - cefpodoxime fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 100 mg/5 mL Carton Label - cefpodoxime fig4

This is a description for a medicine called Rising Cefpodoxime Proxetil, which is an oral suspension that comes in a 50mL bottle. The medicine contains 100mg/5mL of Cefpodoxime Proxetil. It is essential to keep the container tightly closed and store the unconstituted granules at a temperature of 20°C to 25°C. After constituting the granules, the suspension must be refrigerated at 2°C to 8°C. The medicine should be used within 14 days. The available directions provide instructions for mixing the granules and the recommended dose. It also provides information about storing the solution and discarding any unused portion after 14 days.*

Chemical Structure - cefpodoxime str

Chemical Structure - cefpodoxime str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.